Cargando…
Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
BACKGROUND: Epithelial-derived ovarian adenocarcinoma (EOC) is the most deadly gynecologic tumor, and the principle cause of the poor survival rate is diagnosis at a late stage. Screening and diagnostic biomarkers with acceptable specificity and sensitivity are lacking. Ovarian cyst fluid should har...
Autores principales: | Kristjansdottir, Björg, Levan, Kristina, Partheen, Karolina, Carlsohn, Elisabet, Sundfeldt, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637236/ https://www.ncbi.nlm.nih.gov/pubmed/23557354 http://dx.doi.org/10.1186/1559-0275-10-4 |
Ejemplares similares
-
Early inflammatory response in epithelial ovarian tumor cyst fluids
por: Kristjánsdóttir, Björg, et al.
Publicado: (2014) -
Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers
por: Kristjansdottir, Björg, et al.
Publicado: (2012) -
Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
por: Partheen, Karolina, et al.
Publicado: (2011) -
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
por: Partheen, Karolina, et al.
Publicado: (2009) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005)